Literature DB >> 31581903

The research progress of circular RNAs in hematological malignancies.

Tingting Ji1,2, Qiuni Chen1,2, Shandong Tao1,2, Yuye Shi1,2, Yue Chen1,2, Li Shen1,2, Chunling Wang1,2, Liang Yu1,2.   

Abstract

Objectives: Circular RNA (circRNA), a covalently closed loop structure lacking poly-adenylated tails, has attracted attention with the rapid development of its detection techniques such as bioinformatics and RNA sequencing. CircRNA plays important roles in several cell signaling pathways that are associated with cancer biogenesis, including acting as miRNA sponges, transcriptional regulators, protein adaptors and protein translators. The role of circRNA in hematological malignancy has been revealed recently. The purpose of this study was to explore the role of circRNA in hematological malignancy.
Methods: A comprehensive literature review was conducted through Pubmed to summarize the published evidence on the circRNAs in hematological malignancies. English literature sources since 1976 were searched, using the terms circRNA, hematological malignancy.
Results: CircRNAs can regulate the gene expression of hematological malignancies mainly through adsorbing several miRNAs. Some circRNAs are potential biomarkers and therapeutic targets in hematological malignancies, such as acute myloid leukemia (AML), chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL).
Conclusion: CircRNAs play an important biological function and have great diagnostic and prognostic value in hematological malignancies.

Entities:  

Keywords:  AML; CLL; CML; Circular RNA; biomarker; function; hematological malignancy; therapeutic target

Mesh:

Substances:

Year:  2019        PMID: 31581903     DOI: 10.1080/16078454.2019.1669924

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

1.  Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis.

Authors:  Yan Wang; Quande Lin; Chunge Song; Ruojin Ma; Xiaojie Li
Journal:  Cell Cycle       Date:  2020-11-01       Impact factor: 4.534

2.  Homo sapiens circular RNA 0003602 (Hsa_circ_0003602) accelerates the tumorigenicity of acute myeloid leukemia by modulating miR-502-5p/IGF1R axis.

Authors:  Qidong Ye; Nan Li; Kai Zhou; Cong Liao
Journal:  Mol Cell Biochem       Date:  2022-01-06       Impact factor: 3.396

Review 3.  The Non-Coding RNA Landscape of Plasma Cell Dyscrasias.

Authors:  Eugenio Morelli; Annamaria Gullà; Roberta Rocca; Cinzia Federico; Lavinia Raimondi; Stefano Malvestiti; Valter Agosti; Marco Rossi; Giosuè Costa; Gianluca Giavaresi; Kareem A Azab; Antonia Cagnetta; Michele Cea; Pierosandro Tagliaferri; Antonino Neri; Nikhil C Munshi; Giuseppe Viglietto; Pierfrancesco Tassone; Nicola Amodio
Journal:  Cancers (Basel)       Date:  2020-01-30       Impact factor: 6.639

Review 4.  Hypoxia and hypoxia-inducible factor signals regulate the development, metabolism, and function of B cells.

Authors:  Jinwei Zhang; Xiaoqian Wu; Jideng Ma; Keren Long; Jing Sun; Mingzhou Li; Liangpeng Ge
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

5.  Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research.

Authors:  Liusheng Wu; Yanfeng Zhong; Xiaoya Yu; Dingwang Wu; Pengcheng Xu; Le Lv; Xin Ruan; Qi Liu; Yu Feng; Jixian Liu; Xiaoqiang Li
Journal:  Anticancer Drugs       Date:  2022-08-09       Impact factor: 2.389

6.  Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma

Authors:  Yanwei Luo; Rong Gui
Journal:  Turk J Haematol       Date:  2020-08-19       Impact factor: 1.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.